Mead Johnson (MJN) Tops Q2 EPS by 10c, Sales Miss; Reaffirms EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BMO Capital Remains Bullish on Mead Johnson (MJN) Following 2Q Report
July 29, 2016 9:22 AM EDTBMO Capital reiterated an Outperform rating with a $97.00 price target on Mead Johnson Nutrition (NYSE: MJN) following the company's 2Q earnings report. MJN reported EPS of $0.88, above $0.81 estimates. The company reiterated EPS guidance of $3.48-3.60.
Analyst Amit Sharma commented, "MJN reported 2Q16 adjusted EPS of $0.88,... More
Societe Generale Downgrades Mead Johnson Nutrition (MJN) to Hold
July 29, 2016 6:52 AM EDTSociete Generale downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold with a price target of $95.00 (from $100.00).
For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.
Shares of Mead Johnson Nutrition closed at $89.89 yesterday.
... More